Keio Cardiovascular Study on Pathogenesis of Anticancer Drugs Contributing to Cardiovascular Events
Not Applicable
Recruiting
- Conditions
- Cancer
- Registration Number
- JPRN-UMIN000033773
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Not provided
Exclusion Criteria
ineligible for the study as judged by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Frequencies and types of cardiovascular events 2. Investigation of factors associated with the onset of cardiovascular events and clarification of pathogensis of anticancer therapies contributing to cardiovascular damages
- Secondary Outcome Measures
Name Time Method Changes in 1)biomarkers; 2)imagings; and 3)exercise tolerance before and after chemotherapy to treat cancer